PRESS RELEASE
News
-
-
-
PRESS RELEASE
Transaction Update
Arix Bioscience PLC (ARIX) announces the recommended all-share acquisition of its assets by RTW Biotech Opportunities Ltd. The timetable for the scheme remains as set out in the shareholder circular, with the second general meeting to be held on 12 February 2024 in London, United Kingdom -
-
PRESS RELEASE
Holding(s) in Company
Arix Bioscience PLC (ARIX) has announced that Acacia Research Corporation, through its subsidiary Merton Acquisition Holdco LLC, has crossed the threshold of voting rights in the company. This notification is in accordance with the TR-1 standard form for notification of major holdings. -
PRESS RELEASE
Holding(s) in Company
Arix Bioscience PLC (ARIX) has received a notification of major holdings from RTW Investments, LP, and RTW Biotech Opportunities Operating Ltd, indicating an increase to a 25.52% stake in the company. The notification was received on 17/01/2024 and comprises 33,023,210 voting rights. -
PRESS RELEASE
Update on the Scheme and Resignation of Directors
Arix Bioscience PLC provides an update on the recommended all-share acquisition of Arix's assets by RTW Biotech Opportunities Ltd, including the resignation of directors Maureen O'Connell and Isaac Kohlberg. The Scheme's condition related to the Share Purchase has been satisfied, and Arix expects to publish the Shareholder circular later this week. -
-
PRESS RELEASE
PDMR Notification & Director Shareholding
-
PRESS RELEASE
Unaudited NAV for October 2023
-
LaMar’s Donuts Celebrates National Donut Day 2024
-
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
-
abrdn Income Credit Strategies Fund Announces Update and Tentative Closing Date for Acquisition of Assets From First Trust High Income Long/Short Fund
-
Electric Royalties Announces Interest Conversion Under Convertible Credit Facility
-
Pfister Faucets' American Plumber Stories Docuseries Wins Three Telly Awards
-
EQS-Adhoc: Vectron Systems AG: Vectron enters into Business Combination Agreement, resolves 10% capital increase without subscription rights of the shareholders and supports voluntary public acqusition offer
-
CPI PROPERTY GROUP publishes financial results for the first quarter of 2024
-
Leclanché SA: Publishes its Annual Report 2023 and Non-financial ESG Report
-
Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
ACCOR - Description of own share buyback programme
-
ACCOR - Press release following the 2024 general meeting
-
Capital increase through exercise of subscription rights
-
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
-
Thales has completed the sale of its Ground Transportation Systems business